THERMO FISHER SCIENTIFIC

(TMO)
  Report
Delayed Nyse  -  05/27 04:00:02 pm EDT
572.35 USD   +5.97%
05/23Thermo Fisher Scientific and Qatar Genome Program Announce Partnership to Advance Precision Medicine
CI
05/19THERMO FISHER SCIENTIFIC INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
05/19Thermo Fisher Scientific Maintains Quarterly Dividend at $0.30 a Share, Payable July 15 to Shareholders as of June 15
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

THERMO FISHER SCIENTIFIC EXEC SAYS PRICING IS GOING TO BE HIGHER IN 2022 THAN IN PAST YEARS- JPM CONF

01/11/2022 | 08:54am EDT

THERMO FISHER SCIENTIFIC EXEC SAYS PRICING IS GOING TO BE HIGHER IN 2022 THAN IN PAST YEARS- JPM CONF


© Reuters 2022
All news about THERMO FISHER SCIENTIFIC
05/23Thermo Fisher Scientific and Qatar Genome Program Announce Partnership to Advance Preci..
CI
05/19THERMO FISHER SCIENTIFIC INC. : Submission of Matters to a Vote of Security Holders (form ..
AQ
05/19Thermo Fisher Scientific Maintains Quarterly Dividend at $0.30 a Share, Payable July 15..
MT
05/19Thermo Fisher Scientific Declares Quarterly Dividend
BU
05/19Thermo Fisher Scientific Inc. Declares Quarterly Dividend, Payable on July 15, 2022
CI
05/19Thermo Fisher Scientific and LabShares Newton Partner to Support Emerging Boston Biotec..
CI
05/18TRANSCRIPT : Thermo Fisher Scientific Inc. - Analyst/Investor Day
CI
05/11TRANSCRIPT : Thermo Fisher Scientific Inc. Presents at Bank of America 2022 Healthcare Con..
CI
05/11IonPath, Inc. announced that it has received funding from Thermo Fisher Scientific Inc.
CI
05/10Thermo Fisher Scientific Introduces QualTrak Biopharma qPCR Solutions to Streamline Bio..
CI
More news
Analyst Recommendations on THERMO FISHER SCIENTIFIC
More recommendations
Financials (USD)
Sales 2022 42 473 M - -
Net income 2022 6 880 M - -
Net Debt 2022 25 212 M - -
P/E ratio 2022 33,0x
Yield 2022 0,21%
Capitalization 224 B 224 B -
EV / Sales 2022 5,87x
EV / Sales 2023 5,57x
Nbr of Employees 130 000
Free-Float 88,9%
Chart THERMO FISHER SCIENTIFIC
Duration : Period :
Thermo Fisher Scientific Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends THERMO FISHER SCIENTIFIC
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 23
Last Close Price 572,35 $
Average target price 668,21 $
Spread / Average Target 16,7%
EPS Revisions
Managers and Directors
Marc N. Casper Chairman, President & Chief Executive Officer
Stephen Williamson Chief Financial Officer & Senior Vice President
Ryan Snyder Chief Information Officer & Senior Vice President
Alan B. Sachs Chief Medical Officer
Karen E. Nelson Chief Scientific Officer
Sector and Competitors
1st jan.Capi. (M$)
THERMO FISHER SCIENTIFIC-19.05%224 053
DANAHER CORPORATION-19.00%190 779
INTUITIVE SURGICAL, INC.-36.22%82 258
SIEMENS HEALTHINEERS AG-14.49%67 624
EDWARDS LIFESCIENCES CORPORATION-21.95%62 872
BOSTON SCIENTIFIC CORPORATION-3.01%58 898